In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression.
about
In vivo monitoring of mRNA movement in Drosophila body wall muscle cells reveals the presence of myofiber domainsBone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement.Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data.Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource.Effects of irradiating adult mdx mice before full-length dystrophin cDNA transfer on host anti-dystrophin immunityFunctional myogenic engraftment from mouse iPS cells.Satellite cell proliferation and skeletal muscle hypertrophy.Muscle development, regeneration and laminopathies: how lamins or lamina-associated proteins can contribute to muscle development, regeneration and disease.Skeletal muscle as a paradigm for regenerative biology and medicine.Skeletal Muscle-derived Hematopoietic Stem Cells: Muscular Dystrophy Therapy by Bone Marrow Transplantation.Cell therapy strategies and improvements for muscular dystrophy.Characterization and regulation of mechanical loading-induced compensatory muscle hypertrophy.Muscle satellite cells and endothelial cells: close neighbors and privileged partners.Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping.In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy.Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.
P2860
Q27343670-B631C2BA-7068-41BF-BC63-1F1A7EA95A42Q30552419-3572BFF9-F5CF-4AC2-90FF-14FF56DEDBA1Q33785188-2292DA8B-A097-41B6-8571-202548789ABBQ34086953-4CAFEF12-7CFA-4324-AD4F-C3E098B35A7CQ34632501-2A5B9616-B19C-47D9-9ED6-D86D6D2BDFA9Q35735727-5EFC0F0D-F89B-4D8D-8684-E7EA59F6EE55Q36703614-F47052BD-C810-4081-B454-3B161CAAC2EAQ37002317-FE275EC5-7B1B-41E9-8C22-5141E27A2774Q37422514-0836E7CA-C297-4C02-B2C2-AC6AF48B5E48Q37571039-05C8EAD9-8C23-4480-9995-FFC35992C75EQ37624403-A0D7CD1D-CF0D-4C91-9133-469F19D23355Q38110504-57C9AF15-3AE5-4B12-A934-934D002C62E1Q42118907-9D1D8553-541F-43D7-8ACF-FB218E36E974Q47288511-AA4B158B-D3A4-401B-A706-051BB0E1ADD9Q50233651-53863A83-A4D3-43BD-B6B4-121850368CBEQ50721948-60AC156C-78C0-4A5D-B51F-7CF8B9E3B90DQ51812801-04876BF6-D847-415F-AC86-91AAB8E88636
P2860
In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
In vivo fusion of circulating ...... rophin sarcolemmal expression.
@en
type
label
In vivo fusion of circulating ...... rophin sarcolemmal expression.
@en
prefLabel
In vivo fusion of circulating ...... rophin sarcolemmal expression.
@en
P2093
P2860
P1476
In vivo fusion of circulating ...... rophin sarcolemmal expression.
@en
P2093
Bénédicte Chazaud
Christo Christov
Fabrice Chretien
Jean-Léon Lagrange
Patrick A Dreyfus
Philippe Caramelle
Romain K Gherardi
P2860
P304
P356
10.1016/S0002-9440(10)62484-4
P407
P577
2005-06-01T00:00:00Z